Li, Guiyin
Chen, Wei
Mi, Danhong
Wang, Bo
Li, HaiMei
Wu, Guangxiong
Ding, Ping
Liang, Jintao
Zhou, Zhide
Funding for this research was provided by:
Open Fund of Guangxi Key Laboratory of Bio-targeting Theranostics (Nos. GXSWBX201902, GXSWBX201903)
National Nature Science Foundation of China (Nos. 81760534, 82073607)
Article History
Received: 19 March 2022
Revised: 30 May 2022
Accepted: 24 June 2022
First Online: 5 July 2022
Declarations
:
: The human serum samples used in this study were approved by the Guangxi Key Laboratory of Metabolic Diseases Research Ethics Committee in Guilin, China.
: The authors declare no competing interests.